Cartesian Therapeutics, Inc. (RNAC)

7.64 +0.41 (+5.67%) USD  |  NASDAQ  |  Jan 21, 16:00
7.70 +0.06 (+0.79%) Pre-Market: 08:15
More

Cartesian Therapeutics EV to EBIT

EV to EBIT Chart

View EV to EBIT for RNAC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to EBIT Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to EBIT Range, Past 5 Years

View EV to EBIT Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to EBIT Benchmarks

View EV to EBIT Benchmarks
Start Trial
Repligen Corp. Upgrade
Cabaletta Bio, Inc. --
Arcellx, Inc. --
NovaBay Pharmaceuticals, Inc. --
Palatin Technologies, Inc. --

EV to EBIT Related Metrics

EV to CFO Upgrade
EV to Revenues Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade